|
|
|
|
Explore how one organization built upon 15+ years of experience in the clinical-scale supply of ADCs, commercial-scale production of linker payloads, small molecules, and bio-organics, as well as an extensive knowledge base of biologics manufacturing, to establish commercial-scale ADC manufacturing capabilities.
|
|
|
|
|
Through a series of expert-led presentations, industry leaders explore innovative strategies to streamline antibody-drug conjugate (ADC) development and manufacturing. Key topics cover the benefits of an integrated linker-payload and conjugation supply chain, techniques to achieve deep process understanding for right-first-time transfers, and seamless scale-up to GMP manufacturing. Additionally, advancements in process analytical technology (PAT) for bioconjugation are discussed to enhance process efficiency and product quality.
|
|
|
|
|
Gain insight into how antibody-drug conjugate (ADC) chemistry and manufacturing have evolved over the past fifteen years, the challenges this dynamic growth has created, and how CDMOs are adapting to these changes to meet customer needs, now and in the future.
|
|
|
|
|
|
Comprehensive ADC And Bioconjugation Services
|
Discover a trusted CDMO partner with more than 15 years of industry-leading experience in conjugation and purpose-built manufacturing facilities that offers end-to-end services to help bring your ADCs and bioconjugates into the clinic and to commercialization.
|
|
• Request Information
|
|
|
|
|
|
|
|
|
|
|
|
|
ADC And Bioconjugation CDMO Services
|
Antibody-drug conjugates (ADCs) have ignited a new era of targeted cancer therapies but there are several obstacles and complexities to overcome to bring these therapies to market. To solve the challenges and ensure success of your ADC project, you can rely on an industry-leading CDMO partner with 15+ years' experience and focused expertise to meet your ADC development and manufacturing needs, from pre-clinical to commercial.
|
|
|
